Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats

Keiya Takahashi, Hyun Yi, Ching Hang Liu, Shue Liu, Yuta Kashiwagi, Dennis Patin, Shuanglin Hao

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The symptoms of HIV-sensory neuropathy are dominated by neuropathic pain. Recent data show that repeated use of opiates enhances the chronic pain states in HIV patients. Limited attention has so far been devoted to exploring the exact pathogenesis of HIV painful disorder and opiate abuse in vivo, for which there is no effective treatment. Bromodomain-containing protein 4 (Brd4) is a member of the bromodomain and extraterminal domain protein (BET) family and functions as a chromatin 'reader' that binds acetylated lysines in histones in brain neurons to mediate the transcriptional regulation underlying learning and memory. Here, we established a neuropathic pain model of interaction of intrathecal HIV envelope glycoprotein 120 (gp120) and chronic morphine in rats. The combination of gp120 and morphine (gp120/M, for 5 days) induced persistent mechanical allodynia compared with either gp120 or morphine alone. Mechanical allodynia reached the lowest values at day 10 from gp120/M application, beginning to recover from day 21. In the model, gp120/M induced overexpression of Brd4 mRNA and protein at day 10 using RT-qPCR and western blots, respectively. Immunohistochemical studies showed that Brd4 at day 10 was expressed in the neurons of spinal cord dorsal horn. BET inhibitor I-BET762 dose-dependently increased the mechanical threshold in the gp120/M pain state. The present study provides preclinical evidence for treating HIV neuropathic pain with opioids using the BET inhibitor.

Original languageEnglish (US)
Pages (from-to)441-446
Number of pages6
JournalNeuroReport
Volume29
Issue number6
DOIs
StatePublished - Jan 1 2018

Fingerprint

Neuralgia
Morphine
Glycoproteins
HIV
Opiate Alkaloids
Proteins
Hyperalgesia
Neurons
Chronic Pain
Histones
Opioid Analgesics
Lysine
Chromatin
Western Blotting
Learning
Pain
Messenger RNA
Brain

Keywords

  • bromodomain-containing protein 4
  • glycoprotein 120
  • morphine
  • neuropathic pain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats. / Takahashi, Keiya; Yi, Hyun; Liu, Ching Hang; Liu, Shue; Kashiwagi, Yuta; Patin, Dennis; Hao, Shuanglin.

In: NeuroReport, Vol. 29, No. 6, 01.01.2018, p. 441-446.

Research output: Contribution to journalArticle

Takahashi, Keiya ; Yi, Hyun ; Liu, Ching Hang ; Liu, Shue ; Kashiwagi, Yuta ; Patin, Dennis ; Hao, Shuanglin. / Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats. In: NeuroReport. 2018 ; Vol. 29, No. 6. pp. 441-446.
@article{382ff8c2c38642ccad7a5ceb0873ca98,
title = "Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats",
abstract = "The symptoms of HIV-sensory neuropathy are dominated by neuropathic pain. Recent data show that repeated use of opiates enhances the chronic pain states in HIV patients. Limited attention has so far been devoted to exploring the exact pathogenesis of HIV painful disorder and opiate abuse in vivo, for which there is no effective treatment. Bromodomain-containing protein 4 (Brd4) is a member of the bromodomain and extraterminal domain protein (BET) family and functions as a chromatin 'reader' that binds acetylated lysines in histones in brain neurons to mediate the transcriptional regulation underlying learning and memory. Here, we established a neuropathic pain model of interaction of intrathecal HIV envelope glycoprotein 120 (gp120) and chronic morphine in rats. The combination of gp120 and morphine (gp120/M, for 5 days) induced persistent mechanical allodynia compared with either gp120 or morphine alone. Mechanical allodynia reached the lowest values at day 10 from gp120/M application, beginning to recover from day 21. In the model, gp120/M induced overexpression of Brd4 mRNA and protein at day 10 using RT-qPCR and western blots, respectively. Immunohistochemical studies showed that Brd4 at day 10 was expressed in the neurons of spinal cord dorsal horn. BET inhibitor I-BET762 dose-dependently increased the mechanical threshold in the gp120/M pain state. The present study provides preclinical evidence for treating HIV neuropathic pain with opioids using the BET inhibitor.",
keywords = "bromodomain-containing protein 4, glycoprotein 120, morphine, neuropathic pain",
author = "Keiya Takahashi and Hyun Yi and Liu, {Ching Hang} and Shue Liu and Yuta Kashiwagi and Dennis Patin and Shuanglin Hao",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/WNR.0000000000000992",
language = "English (US)",
volume = "29",
pages = "441--446",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats

AU - Takahashi, Keiya

AU - Yi, Hyun

AU - Liu, Ching Hang

AU - Liu, Shue

AU - Kashiwagi, Yuta

AU - Patin, Dennis

AU - Hao, Shuanglin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The symptoms of HIV-sensory neuropathy are dominated by neuropathic pain. Recent data show that repeated use of opiates enhances the chronic pain states in HIV patients. Limited attention has so far been devoted to exploring the exact pathogenesis of HIV painful disorder and opiate abuse in vivo, for which there is no effective treatment. Bromodomain-containing protein 4 (Brd4) is a member of the bromodomain and extraterminal domain protein (BET) family and functions as a chromatin 'reader' that binds acetylated lysines in histones in brain neurons to mediate the transcriptional regulation underlying learning and memory. Here, we established a neuropathic pain model of interaction of intrathecal HIV envelope glycoprotein 120 (gp120) and chronic morphine in rats. The combination of gp120 and morphine (gp120/M, for 5 days) induced persistent mechanical allodynia compared with either gp120 or morphine alone. Mechanical allodynia reached the lowest values at day 10 from gp120/M application, beginning to recover from day 21. In the model, gp120/M induced overexpression of Brd4 mRNA and protein at day 10 using RT-qPCR and western blots, respectively. Immunohistochemical studies showed that Brd4 at day 10 was expressed in the neurons of spinal cord dorsal horn. BET inhibitor I-BET762 dose-dependently increased the mechanical threshold in the gp120/M pain state. The present study provides preclinical evidence for treating HIV neuropathic pain with opioids using the BET inhibitor.

AB - The symptoms of HIV-sensory neuropathy are dominated by neuropathic pain. Recent data show that repeated use of opiates enhances the chronic pain states in HIV patients. Limited attention has so far been devoted to exploring the exact pathogenesis of HIV painful disorder and opiate abuse in vivo, for which there is no effective treatment. Bromodomain-containing protein 4 (Brd4) is a member of the bromodomain and extraterminal domain protein (BET) family and functions as a chromatin 'reader' that binds acetylated lysines in histones in brain neurons to mediate the transcriptional regulation underlying learning and memory. Here, we established a neuropathic pain model of interaction of intrathecal HIV envelope glycoprotein 120 (gp120) and chronic morphine in rats. The combination of gp120 and morphine (gp120/M, for 5 days) induced persistent mechanical allodynia compared with either gp120 or morphine alone. Mechanical allodynia reached the lowest values at day 10 from gp120/M application, beginning to recover from day 21. In the model, gp120/M induced overexpression of Brd4 mRNA and protein at day 10 using RT-qPCR and western blots, respectively. Immunohistochemical studies showed that Brd4 at day 10 was expressed in the neurons of spinal cord dorsal horn. BET inhibitor I-BET762 dose-dependently increased the mechanical threshold in the gp120/M pain state. The present study provides preclinical evidence for treating HIV neuropathic pain with opioids using the BET inhibitor.

KW - bromodomain-containing protein 4

KW - glycoprotein 120

KW - morphine

KW - neuropathic pain

UR - http://www.scopus.com/inward/record.url?scp=85045005199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045005199&partnerID=8YFLogxK

U2 - 10.1097/WNR.0000000000000992

DO - 10.1097/WNR.0000000000000992

M3 - Article

C2 - 29465625

AN - SCOPUS:85045005199

VL - 29

SP - 441

EP - 446

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 6

ER -